SPAC Presentation

What Makes Us a Unique Investment Case? Compelling Investment Case 1 PROCAPS 6 GROUP Leading Regional Pharmaceutical Player¹ with Global Reach and Highly Accomplished Management Team 2 5 In-House R&D Capabilities Driving Attractive Growth Opportunities 3 Leading Pharmaceutical Integral CDMO Specialized in Softgels 4 Proprietary Portfolio of Branded Rx and OTC Products Positioned to Capitalize on Favorable Regional Dynamics Strong History and Focus ESG Principles PROCAPS Source: Procaps, QYR Research Note: (1) Top 3 Player Globally for Softgel Production Capacity. QYR Research market report as of 2020 GROUP * 15

View entire presentation